New molecular strategies to cure brain tumors

H Fathallah-Shaykh1

  • 1Department of Neurology, University of Texas Southwestern Medical Center, Dallas 75235-9036, USA. fathalla@utsw.swmed.edu

Archives of Neurology
|April 13, 1999
PubMed

Insights

Malignant brain tumors remain lethal, with limited success from traditional therapies. Emerging molecular medicine strategies like gene therapy, antiangiogenesis, and immunotherapy offer new hope for targeting cancer cells.

Area of Science:

  • Oncology
  • Molecular Medicine
  • Cancer Therapeutics

Background:

  • Malignant primary and metastatic brain tumors have shown persistent lethality from the 1970s to the 1990s.
  • Conventional treatments like radiation therapy and chemotherapy have provided only marginal improvements in survival rates.

Purpose of the Study:

  • To review emerging therapeutic strategies for malignant brain tumors.
  • To highlight advancements in molecular medicine for cancer treatment.

Main Methods:

  • Review of emerging strategies including gene therapy, antiangiogenesis, and immunotherapy.
  • Discussion of novel tools for targeting malignant cells.

Main Results:

  • Molecular medicine discoveries have enhanced understanding of tumorigenesis.
  • Novel treatment modalities are under investigation in pre-clinical and clinical settings.

Conclusions:

  • Emerging strategies like gene therapy, antiangiogenesis, and immunotherapy show promise for brain tumor treatment.
  • Targeting malignant cells through novel approaches represents a significant advancement in oncology.